These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12841010)

  • 1. Hyperthermia and liposomal encapsulated doxorubicin.
    Ben-Yosef R; Gipps M; Zeira M
    Isr Med Assoc J; 2003 Jun; 5(6):407-9. PubMed ID: 12841010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of antitumor activity of polyethylene glycol-coated liposomal doxorubicin with soluble and liposomal interleukin 2.
    Cabanes A; Even-Chen S; Zimberoff J; Barenholz Y; Kedar E; Gabizon A
    Clin Cancer Res; 1999 Mar; 5(3):687-93. PubMed ID: 10100723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fever-range whole body hyperthermia increases the number of perfused tumor blood vessels and therapeutic efficacy of liposomally encapsulated doxorubicin.
    Xu Y; Choi J; Hylander B; Sen A; Evans SS; Kraybill WG; Repasky EA
    Int J Hyperthermia; 2007 Sep; 23(6):513-27. PubMed ID: 17952765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin products?
    Mamidi RN; Weng S; Stellar S; Wang C; Yu N; Huang T; Tonelli AP; Kelley MF; Angiuoli A; Fung MC
    Cancer Chemother Pharmacol; 2010 Nov; 66(6):1173-84. PubMed ID: 20661737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
    Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tracer dose of technetium-99m-labeled liposomes can estimate the effect of hyperthermia on intratumoral doxil extravasation.
    Kleiter MM; Yu D; Mohammadian LA; Niehaus N; Spasojevic I; Sanders L; Viglianti BL; Yarmolenko PS; Hauck M; Petry NA; Wong TZ; Dewhirst MW; Thrall DE
    Clin Cancer Res; 2006 Nov; 12(22):6800-7. PubMed ID: 17121901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the antitumor activity of free doxorubicin and polyethylene glycol-coated liposomal doxorubicin in a mouse lymphoma model.
    Cabanes A; Tzemach D; Goren D; Horowitz AT; Gabizon A
    Clin Cancer Res; 1998 Feb; 4(2):499-505. PubMed ID: 9516942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes.
    Huang SK; Stauffer PR; Hong K; Guo JW; Phillips TL; Huang A; Papahadjopoulos D
    Cancer Res; 1994 Apr; 54(8):2186-91. PubMed ID: 8174126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency thermal ablation sharply increases intratumoral liposomal doxorubicin accumulation and tumor coagulation.
    Ahmed M; Monsky WE; Girnun G; Lukyanov A; D'Ippolito G; Kruskal JB; Stuart KE; Torchilin VP; Goldberg SN
    Cancer Res; 2003 Oct; 63(19):6327-33. PubMed ID: 14559820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of liposomal doxorubicin (Doxil) in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure.
    Frenkel V; Etherington A; Greene M; Quijano J; Xie J; Hunter F; Dromi S; Li KC
    Acad Radiol; 2006 Apr; 13(4):469-79. PubMed ID: 16554227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct injection of liposome-encapsulated doxorubicin optimizes chemomyectomy in rabbit eyelid.
    McLoon LK; Wirtschafter JD
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2561-7. PubMed ID: 10509650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three approaches to doxorubicin therapy: free doxorubicin, liposomal doxorubicin, and beta-glucuronidase-activated prodrug (HMR 1826).
    Woessner R; An Z; Li X; Hoffman RM; Dix R; Bitonti A
    Anticancer Res; 2000; 20(4):2289-96. PubMed ID: 10953287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced therapeutic effect against liver W256 carcinosarcoma with temperature-sensitive liposomal adriamycin administered into the hepatic artery.
    Zou Y; Yamagishi M; Horikoshi I; Ueno M; Gu X; Perez-Soler R
    Cancer Res; 1993 Jul; 53(13):3046-51. PubMed ID: 8319211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects.
    Ponce AM; Viglianti BL; Yu D; Yarmolenko PS; Michelich CR; Woo J; Bally MB; Dewhirst MW
    J Natl Cancer Inst; 2007 Jan; 99(1):53-63. PubMed ID: 17202113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I/II trial of intravenous Doxil and whole abdomen hyperthermia in patients with refractory ovarian cancer.
    Alvarez Secord A; Jones EL; Hahn CA; Petros WP; Yu D; Havrilesky LJ; Soper JT; Berchuck A; Spasojevic I; Clarke-Pearson DL; Prosnitz LR; Dewhirst MW
    Int J Hyperthermia; 2005 Jun; 21(4):333-47. PubMed ID: 16019859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple injections of pegylated liposomal Doxorubicin: pharmacokinetics and therapeutic activity.
    Charrois GJ; Allen TM
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1058-67. PubMed ID: 12808004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of doxorubicin thermosensitive liposomes (40 degrees C) and local hyperthermia on rat rhabdomyosarcoma.
    Morita K; Zywietz F; Kakinuma K; Tanaka R; Katoh M
    Oncol Rep; 2008 Aug; 20(2):365-72. PubMed ID: 18636199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors.
    Laginha KM; Verwoert S; Charrois GJ; Allen TM
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6944-9. PubMed ID: 16203786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin has a highly antitumor effect in an experimental pulmonary metastatic mouse model.
    Shiraga E; Barichello JM; Ishida T; Kiwada H
    Int J Pharm; 2008 Apr; 353(1-2):65-73. PubMed ID: 18155369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose dependency of pharmacokinetics and therapeutic efficacy of pegylated liposomal doxorubicin (DOXIL) in murine models.
    Gabizon A; Tzemach D; Mak L; Bronstein M; Horowitz AT
    J Drug Target; 2002 Nov; 10(7):539-48. PubMed ID: 12683721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.